Some clients arrive at FDA medical device development without an existing quality system or a clear path to one. The framework has to be built, or substantially adjusted, before product engineering can move at all. The clients below each came to Good Automation early in that arc, with the regulatory question on the table, not just the engineering question.
Good Automation engaged each client on the regulatory framing first: validation strategy and 21 CFR Part 11 implications for a Class III Software as a Medical Device, on-the-ground FDA quality system training for a foreign company entering the US market, and a minimally viable QMS plus design history file for university researchers moving lab work toward commercialization. Three different starting points, one consistent posture: regulatory clarity is faster and cheaper than retrofitting compliance later.